{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:27:48Z","timestamp":1792070868426,"version":"4.4.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"MOH | National Medical Research Council","doi-asserted-by":"publisher","award":["CBRG\/0106\/2016"],"award-info":[{"award-number":["CBRG\/0106\/2016"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/11\/25\/28740"],"award-info":[{"award-number":["FS\/11\/25\/28740"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cardiac fibrosis is a final common pathology in inherited and acquired heart diseases that causes cardiac electrical and pump failure. Here, we use systems genetics to identify a pro-fibrotic gene network in the diseased heart and show that this network is regulated by the E3 ubiquitin ligase\n                    <jats:italic>WWP2<\/jats:italic>\n                    , specifically by the\n                    <jats:italic>WWP2-N<\/jats:italic>\n                    terminal isoform. Importantly, the\n                    <jats:italic>WWP2<\/jats:italic>\n                    -regulated pro-fibrotic gene network is conserved across different cardiac diseases characterized by fibrosis: human and murine dilated cardiomyopathy and repaired tetralogy of Fallot. Transgenic mice lacking the N-terminal region of the WWP2 protein show improved cardiac function and reduced myocardial fibrosis in response to pressure overload or myocardial infarction. In primary cardiac fibroblasts, WWP2 positively regulates the expression of pro-fibrotic markers and extracellular matrix genes. TGF\u03b21 stimulation promotes nuclear translocation of the WWP2 isoforms containing the N-terminal region and their interaction with SMAD2. WWP2 mediates the TGF\u03b21-induced nucleocytoplasmic shuttling and transcriptional activity of SMAD2.\n                  <\/jats:p>","DOI":"10.1038\/s41467-019-11551-9","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T06:02:38Z","timestamp":1565330558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling"],"prefix":"10.1038","volume":"10","author":[{"given":"Huimei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-3146","authenticated-orcid":false,"given":"Aida","family":"Moreno-Moral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Devapragash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ee Ling","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Rotival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Harmston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Shkura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen J. L.","family":"Rackham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-Ming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Gui Zhen","family":"Tee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Li Sa","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1165-7767","authenticated-orcid":false,"given":"Paul J. R.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne E.","family":"Felkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Lara-Pezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Pravenec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6909-8275","authenticated-orcid":false,"given":"Sebastian","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6381-2327","authenticated-orcid":false,"given":"Leonardo","family":"Bottolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Hubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Emanueli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6628-194X","authenticated-orcid":false,"given":"Stuart A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-5921","authenticated-orcid":false,"given":"Enrico","family":"Petretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"11551_CR1","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E. & Blaxall, B. C. Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118, 1021\u20131040 (2016).","journal-title":"Circ. Res"},{"key":"11551_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jama.2013.1363","volume":"309","author":"A Gulati","year":"2013","unstructured":"Gulati, A. et al. Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA 309, 896\u2013908 (2013).","journal-title":"JAMA"},{"key":"11551_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.hfc.2017.12.004","volume":"14","author":"AC Garfinkel","year":"2018","unstructured":"Garfinkel, A. C., Seidman, J. G. & Seidman, C. E. Genetic pathogenesis of hypertrophic and dilated cardiomyopathy. Heart Fail. Clin. 14, 139\u2013146 (2018).","journal-title":"Heart Fail. Clin."},{"key":"11551_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1083\/jcb.201101100","volume":"194","author":"PA Harvey","year":"2011","unstructured":"Harvey, P. A. & Leinwand, L. A. The cell biology of disease: cellular mechanisms of cardiomyopathy. J. Cell Biol. 194, 355\u2013365 (2011).","journal-title":"J. Cell Biol."},{"key":"11551_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ejhf.696","volume":"19","author":"M Gyongyosi","year":"2017","unstructured":"Gyongyosi, M. et al. Myocardial fibrosis: biomedical research from bench to bedside. Eur. J. Heart Fail. 19, 177\u2013191 (2017).","journal-title":"Eur. J. Heart Fail"},{"key":"11551_CR6","doi-asserted-by":"publisher","first-page":"91625","DOI":"10.1172\/jci.insight.91625","volume":"2","author":"S Reddy","year":"2017","unstructured":"Reddy, S. et al. miR-21 is associated with fibrosis and right ventricular failure. JCI Insight 2, 91625 (2017).","journal-title":"JCI Insight"},{"key":"11551_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1056\/NEJMra1300575","volume":"372","author":"DC Rockey","year":"2015","unstructured":"Rockey, D. C., Bell, P. D. & Hill, J. A. Fibrosis\u2014a common pathway to organ injury and failure. N. Engl. J. Med. 372, 1138\u20131149 (2015).","journal-title":"N. Engl. J. Med."},{"key":"11551_CR8","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/FJC.0b013e3182116e39","volume":"57","author":"J Baum","year":"2011","unstructured":"Baum, J. & Duffy, H. S. Fibroblasts and myofibroblasts: what are we talking about? J. Cardiovasc. Pharm. 57, 376\u2013379 (2011).","journal-title":"J. Cardiovasc. Pharm."},{"key":"11551_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature24676","volume":"552","author":"S Schafer","year":"2017","unstructured":"Schafer, S. et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature 552, 110\u2013115 (2017).","journal-title":"Nature"},{"key":"11551_CR10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/CIRCRESAHA.116.305381","volume":"116","author":"A Leask","year":"2015","unstructured":"Leask, A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ. Res. 116, 1269\u20131276 (2015).","journal-title":"Circ. Res."},{"key":"11551_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-1536-4-4","volume":"4","author":"Q Wang","year":"2011","unstructured":"Wang, Q. et al. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenes Tissue Repair 4, 4 (2011).","journal-title":"Fibrogenes Tissue Repair"},{"key":"11551_CR12","first-page":"59","volume":"2","author":"B Piersma","year":"2015","unstructured":"Piersma, B., Bank, R. A. & Boersema, M. Signaling in fibrosis: TGF-beta, WNT, and YAP\/TAZ converge. Front. Med. 2, 59 (2015).","journal-title":"Front. Med. (Lausanne)"},{"key":"11551_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cardiores.2006.07.012","volume":"74","author":"A Leask","year":"2007","unstructured":"Leask, A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc. Res. 74, 207\u2013212 (2007).","journal-title":"Cardiovasc. Res"},{"key":"11551_CR14","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.biocel.2007.09.006","volume":"40","author":"S Ross","year":"2008","unstructured":"Ross, S. & Hill, C. S. How the Smads regulate transcription. Int. J. Biochem. Cell Biol. 40, 383\u2013408 (2008).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"11551_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-016-0060-8","volume":"20","author":"Z Fan","year":"2016","unstructured":"Fan, Z. & Guan, J. Antifibrotic therapies to control cardiac fibrosis. Biomater. Res. 20, 13 (2016).","journal-title":"Biomater. Res"},{"key":"11551_CR16","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","volume":"106","author":"A Leask","year":"2010","unstructured":"Leask, A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 106, 1675\u20131680 (2010).","journal-title":"Circ. Res."},{"key":"11551_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.matbio.2017.12.016","volume":"68-69","author":"AH Gyorfi","year":"2018","unstructured":"Gyorfi, A. H., Matei, A. E. & Distler, J. H. W. Targeting TGF-beta signaling for the treatment of fibrosis. Matrix Biol. 68\u201369, 8\u201327 (2018).","journal-title":"Matrix Biol."},{"key":"11551_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/978-1-4939-6427-7_16","volume":"1488","author":"A Moreno-Moral","year":"2017","unstructured":"Moreno-Moral, A., Pesce, F., Behmoaras, J. & Petretto, E. Systems genetics as a tool to identify master genetic regulators in complex disease. Methods Mol. Biol. 1488, 337\u2013362 (2017).","journal-title":"Methods Mol. Biol."},{"key":"11551_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/ng1522","volume":"37","author":"N Hubner","year":"2005","unstructured":"Hubner, N. et al. Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease. Nat. Genet. 37, 243\u2013253 (2005).","journal-title":"Nat. Genet"},{"key":"11551_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ng.134","volume":"40","author":"E Petretto","year":"2008","unstructured":"Petretto, E. et al. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat. Genet. 40, 546\u2013552 (2008).","journal-title":"Nat. Genet."},{"key":"11551_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00395-012-0316-y","volume":"108","author":"M Mancini","year":"2013","unstructured":"Mancini, M. et al. Mapping genetic determinants of coronary microvascular remodeling in the spontaneously hypertensive rat. Basic Res. Cardiol. 108, 316 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"11551_CR22","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/cvr\/cvs329","volume":"97","author":"SR Langley","year":"2013","unstructured":"Langley, S. R. et al. Systems-level approaches reveal conservation of trans-regulated genes in the rat and genetic determinants of blood pressure in humans. Cardiovasc. Res. 97, 653\u2013665 (2013).","journal-title":"Cardiovasc. Res."},{"key":"11551_CR23","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ng.164","volume":"40","author":"M Pravenec","year":"2008","unstructured":"Pravenec, M. et al. Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension. Nat. Genet. 40, 952\u2013954 (2008).","journal-title":"Nat. Genet"},{"key":"11551_CR24","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s12265-013-9504-x","volume":"6","author":"A Moreno-Moral","year":"2013","unstructured":"Moreno-Moral, A., Mancini, M., D\u2019Amati, G., Camici, P. & Petretto, E. Transcriptional network analysis for the regulation of left ventricular hypertrophy and microvascular remodeling. J. Cardiovasc. Transl. Res. 6, 931\u2013944 (2013).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"11551_CR25","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11551_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1286-z","volume":"18","author":"M Heinig","year":"2017","unstructured":"Heinig, M. et al. Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy. Genome Biol. 18, 170 (2017).","journal-title":"Genome Biol."},{"key":"11551_CR27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/bfgp\/elt030","volume":"13","author":"M Rotival","year":"2014","unstructured":"Rotival, M. & Petretto, E. Leveraging gene co-expression networks to pinpoint the regulation of complex traits and disease, with a focus on cardiovascular traits. Brief. Funct. Genomics 13, 66\u201378 (2014).","journal-title":"Brief. Funct. Genomics"},{"key":"11551_CR28","doi-asserted-by":"publisher","first-page":"H1719","DOI":"10.1152\/ajpheart.00130.2013","volume":"304","author":"T Zhao","year":"2013","unstructured":"Zhao, T. et al. Platelet-derived growth factor-D promotes fibrogenesis of cardiac fibroblasts. Am. J. Physiol. Heart Circ. Physiol. 304, H1719\u2013H1726 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"11551_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.carpath.2016.02.001","volume":"25","author":"N Pradegan","year":"2016","unstructured":"Pradegan, N. et al. Myocardial histopathology in late-repaired and unrepaired adults with tetralogy of Fallot. Cardiovasc. Pathol. 25, 225\u2013231 (2016).","journal-title":"Cardiovasc. Pathol."},{"key":"11551_CR30","doi-asserted-by":"publisher","first-page":"e86898","DOI":"10.1172\/jci.insight.86898","volume":"1","author":"MA Burke","year":"2016","unstructured":"Burke, M. A. et al. Molecular profiling of dilated cardiomyopathy that progresses to heart failure. JCI Insight 1, e86898 (2016).","journal-title":"JCI Insight"},{"key":"11551_CR31","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/emboj\/19.8.1745","volume":"19","author":"J Massague","year":"2000","unstructured":"Massague, J. & Wotton, D. Transcriptional control by the TGF-beta\/Smad signaling system. EMBO J. 19, 1745\u20131754 (2000).","journal-title":"EMBO J."},{"key":"11551_CR32","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1093\/bioinformatics\/btq466","volume":"26","author":"A Lachmann","year":"2010","unstructured":"Lachmann, A. et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments. Bioinformatics 26, 2438\u20132444 (2010).","journal-title":"Bioinformatics"},{"key":"11551_CR33","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1534\/genetics.111.131425","volume":"189","author":"L Bottolo","year":"2011","unstructured":"Bottolo, L. et al. Bayesian detection of expression quantitative trait loci hot spots. Genetics 189, 1449\u20131459 (2011).","journal-title":"Genetics"},{"key":"11551_CR34","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nature09386","volume":"467","author":"M Heinig","year":"2010","unstructured":"Heinig, M. et al. A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature 467, 460\u2013464 (2010).","journal-title":"Nature"},{"key":"11551_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7031","volume":"6","author":"MR Johnson","year":"2015","unstructured":"Johnson, M. R. et al. Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus. Nat. Commun. 6, 6031 (2015).","journal-title":"Nat. Commun."},{"key":"11551_CR36","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.celrep.2014.07.032","volume":"8","author":"H Kang","year":"2014","unstructured":"Kang, H. et al. Kcnn4 is a regulator of macrophage multinucleation in bone homeostasis and inflammatory disease. Cell Rep. 8, 1210\u20131224 (2014).","journal-title":"Cell Rep."},{"key":"11551_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1172\/JCI22304","volume":"115","author":"S Matsumura","year":"2005","unstructured":"Matsumura, S. et al. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J. Clin. Invest. 115, 599\u2013609 (2005).","journal-title":"J. Clin. Invest."},{"key":"11551_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0008-6363(00)00029-8","volume":"46","author":"JT Peterson","year":"2000","unstructured":"Peterson, J. T., Li, H., Dillon, L. & Bryant, J. W. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 46, 307\u2013315 (2000).","journal-title":"Cardiovasc. Res."},{"key":"11551_CR39","doi-asserted-by":"publisher","first-page":"e0181945","DOI":"10.1371\/journal.pone.0181945","volume":"12","author":"JA Schwanekamp","year":"2017","unstructured":"Schwanekamp, J. A. et al. TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury. PLoS ONE 12, e0181945 (2017).","journal-title":"PLoS ONE"},{"key":"11551_CR40","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1038\/onc.2010.617","volume":"30","author":"SM Soond","year":"2011","unstructured":"Soond, S. M. & Chantry, A. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFbeta signalling and EMT. Oncogene 30, 2451\u20132462 (2011).","journal-title":"Oncogene"},{"key":"11551_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/ncb2134","volume":"13","author":"W Zou","year":"2011","unstructured":"Zou, W. et al. The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of Goosecoid. Nat. Cell Biol. 13, 59\u201365 (2011).","journal-title":"Nat. Cell Biol."},{"key":"11551_CR42","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1038\/jid.2015.86","volume":"135","author":"M Schmidt","year":"2015","unstructured":"Schmidt, M. et al. Controlling the balance of fibroblast proliferation and differentiation: impact of Thy-1. J. Invest. Dermatol. 135, 1893\u20131902 (2015).","journal-title":"J. Invest. Dermatol."},{"key":"11551_CR43","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1073\/pnas.0610481104","volume":"104","author":"AA Horwitz","year":"2007","unstructured":"Horwitz, A. A., Affar, E. L. B., Heine, G. F., Shi, Y. & Parvin, J. D. A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase. Proc. Natl Acad. Sci. USA 104, 6614\u20136619 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11551_CR44","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/cells3040981","volume":"3","author":"F Xie","year":"2014","unstructured":"Xie, F., Zhang, Z., van Dam, H., Zhang, L. & Zhou, F. Regulation of TGF-beta superfamily signaling by SMAD mono-ubiquitination. Cells 3, 981\u2013993 (2014).","journal-title":"Cells"},{"key":"11551_CR45","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1038\/emboj.2011.393","volume":"30","author":"LY Tang","year":"2011","unstructured":"Tang, L. Y. et al. Ablation of Smurf2 reveals an inhibition in TGF-beta signalling through multiple mono-ubiquitination of Smad3. EMBO J. 30, 4777\u20134789 (2011).","journal-title":"EMBO J."},{"key":"11551_CR46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrm1331","volume":"5","author":"L Xu","year":"2004","unstructured":"Xu, L. & Massague, J. Nucleocytoplasmic shuttling of signal transducers. Nat. Rev. Mol. Cell Biol. 5, 209\u2013219 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"11551_CR47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1097-2765(02)00585-3","volume":"10","author":"GJ Inman","year":"2002","unstructured":"Inman, G. J., Nicolas, F. J. & Hill, C. S. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol. Cell 10, 283\u2013294 (2002).","journal-title":"Mol. Cell"},{"key":"11551_CR48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1124\/mol.62.1.65","volume":"62","author":"GJ Inman","year":"2002","unstructured":"Inman, G. J. et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharm. 62, 65\u201374 (2002).","journal-title":"Mol. Pharm."},{"key":"11551_CR49","doi-asserted-by":"publisher","first-page":"9845","DOI":"10.1128\/MCB.25.22.9845-9858.2005","volume":"25","author":"B Schmierer","year":"2005","unstructured":"Schmierer, B. & Hill, C. S. Kinetic analysis of Smad nucleocytoplasmic shuttling reveals a mechanism for transforming growth factor beta-dependent nuclear accumulation of Smads. Mol. Cell Biol. 25, 9845\u20139858 (2005).","journal-title":"Mol. Cell Biol."},{"key":"11551_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1242","volume":"2","author":"Y Nakamura","year":"2011","unstructured":"Nakamura, Y. et al. Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat. Commun. 2, 251 (2011).","journal-title":"Nat. Commun."},{"key":"11551_CR51","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1073\/pnas.1220271110","volume":"110","author":"Y Yang","year":"2013","unstructured":"Yang, Y. et al. E3 ligase WWP2 negatively regulates TLR3-mediated innate immune response by targeting TRIF for ubiquitination and degradation. Proc. Natl Acad. Sci. USA 110, 5115\u20135120 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"11551_CR52","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ncb2240","volume":"13","author":"S Maddika","year":"2011","unstructured":"Maddika, S. et al. WWP2 is an E3 ubiquitin ligase for PTEN. Nat. Cell Biol. 13, 728\u2013733 (2011).","journal-title":"Nat. Cell Biol."},{"key":"11551_CR53","doi-asserted-by":"publisher","first-page":"807","DOI":"10.18632\/oncoscience.101","volume":"1","author":"C Fukumoto","year":"2014","unstructured":"Fukumoto, C. et al. WWP2 is overexpressed in human oral cancer, determining tumor size and poor prognosis in patients: downregulation of WWP2 inhibits the AKT signaling and tumor growth in mice. Oncoscience 1, 807\u2013820 (2014).","journal-title":"Oncoscience"},{"key":"11551_CR54","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/s-0044-100280","volume":"39","author":"SK Kim","year":"2018","unstructured":"Kim, S. K. et al. Two genetic variants associated with plantar fascial disorders. Int J. Sports Med. 39, 314\u2013321 (2018).","journal-title":"Int J. Sports Med."},{"key":"11551_CR55","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41588-018-0247-0","volume":"50","author":"U Styrkarsdottir","year":"2018","unstructured":"Styrkarsdottir, U. et al. Meta-analysis of Icelandic and UK data sets identifies missense variants in SMO, IL11, COL11A1 and 13 more new loci associated with osteoarthritis. Nat. Genet. 50, 1681\u20131687 (2018).","journal-title":"Nat. Genet"},{"key":"11551_CR56","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil, H. et al. Fibroblast-specific TGF-beta-Smad2\/3 signaling underlies cardiac fibrosis. J. Clin. Invest. 127, 3770\u20133783 (2017).","journal-title":"J. Clin. Invest"},{"key":"11551_CR57","doi-asserted-by":"publisher","first-page":"25427","DOI":"10.1074\/jbc.M115.646984","volume":"290","author":"K Bernard","year":"2015","unstructured":"Bernard, K. et al. Metabolic reprogramming is required for myofibroblast contractility and differentiation. J. Biol. Chem. 290, 25427\u201325438 (2015).","journal-title":"J. Biol. Chem."},{"key":"11551_CR58","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/qjmed\/hcu162","volume":"109","author":"B Selvarajah","year":"2016","unstructured":"Selvarajah, B. et al. Metabolic shift during TGF-\u03b2 induced collagen synthesis. QJM 109, S3 (2016).","journal-title":"QJM"},{"key":"11551_CR59","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3902","volume":"21","author":"S Lovisa","year":"2015","unstructured":"Lovisa, S. et al. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat. Med. 21, 998\u20131009 (2015).","journal-title":"Nat. Med"},{"key":"11551_CR60","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/dvdy.22280","volume":"239","author":"JJ Santiago","year":"2010","unstructured":"Santiago, J. J. et al. Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts. Dev. Dyn. 239, 1573\u20131584 (2010).","journal-title":"Dev. Dyn."},{"key":"11551_CR61","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/70258","volume":"1","author":"RS Lo","year":"1999","unstructured":"Lo, R. S. & Massague, J. Ubiquitin-dependent degradation of TGF-beta-activated smad2. Nat. Cell Biol. 1, 472\u2013478 (1999).","journal-title":"Nat. Cell Biol."},{"key":"11551_CR62","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/cr.2008.325","volume":"19","author":"CS Hill","year":"2009","unstructured":"Hill, C. S. Nucleocytoplasmic shuttling of Smad proteins. Cell Res. 19, 36\u201346 (2009).","journal-title":"Cell Res."},{"key":"11551_CR63","doi-asserted-by":"publisher","first-page":"35857","DOI":"10.1074\/jbc.R300018200","volume":"278","author":"JD Schnell","year":"2003","unstructured":"Schnell, J. D. & Hicke, L. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J. Biol. Chem. 278, 35857\u201335860 (2003).","journal-title":"J. Biol. Chem."},{"key":"11551_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cell.2006.11.040","volume":"128","author":"LC Trotman","year":"2007","unstructured":"Trotman, L. C. et al. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128, 141\u2013156 (2007).","journal-title":"Cell"},{"key":"11551_CR65","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1038\/ncb2346","volume":"13","author":"M Inui","year":"2011","unstructured":"Inui, M. et al. USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat. Cell Biol. 13, 1368\u20131375 (2011).","journal-title":"Nat. Cell Biol."},{"key":"11551_CR66","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/2045-3701-1-43","volume":"1","author":"LY Tang","year":"2011","unstructured":"Tang, L. Y. & Zhang, Y. E. Non-degradative ubiquitination in Smad-dependent TGF-beta signaling. Cell Biosci. 1, 43 (2011).","journal-title":"Cell Biosci."},{"key":"11551_CR67","doi-asserted-by":"publisher","first-page":"22804","DOI":"10.1074\/jbc.M700961200","volume":"282","author":"CL Brooks","year":"2007","unstructured":"Brooks, C. L., Li, M. & Gu, W. Mechanistic studies of MDM2-mediated ubiquitination in p53 regulation. J. Biol. Chem. 282, 22804\u201322815 (2007).","journal-title":"J. Biol. Chem."},{"key":"11551_CR68","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2174\/156800911794519734","volume":"11","author":"L Jia","year":"2011","unstructured":"Jia, L. & Sun, Y. SCF E3 ubiquitin ligases as anticancer targets. Curr. Cancer Drug Targets 11, 347\u2013356 (2011).","journal-title":"Curr. Cancer Drug Targets"},{"key":"11551_CR69","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/cr.2016.31","volume":"26","author":"X Huang","year":"2016","unstructured":"Huang, X. & Dixit, V. M. Drugging the undruggables: exploring the ubiquitin system for drug development. Cell Res. 26, 484\u2013498 (2016).","journal-title":"Cell Res."},{"key":"11551_CR70","doi-asserted-by":"publisher","first-page":"eaao3003","DOI":"10.1126\/scitranslmed.aao3003","volume":"10","author":"LA Carvajal","year":"2018","unstructured":"Carvajal, L. A. et al. Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia. Sci. Transl. Med. 10, eaao3003 (2018).","journal-title":"Sci. Transl. Med."},{"key":"11551_CR71","doi-asserted-by":"publisher","first-page":"933","DOI":"10.3892\/or.2017.5713","volume":"38","author":"L Ding","year":"2017","unstructured":"Ding, L. et al. Inhibition of Skp2 suppresses the proliferation and invasion of osteosarcoma cells. Oncol. Rep. 38, 933\u2013940 (2017).","journal-title":"Oncol. Rep."},{"key":"11551_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellimm.2016.07.003","volume":"306-307","author":"XL Huang","year":"2016","unstructured":"Huang, X. L. et al. E3 ubiquitin ligase: a potential regulator in fibrosis and systemic sclerosis. Cell Immunol. 306-307, 1\u20138 (2016).","journal-title":"Cell Immunol."},{"key":"11551_CR73","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s10741-012-9365-4","volume":"19","author":"AM Segura","year":"2014","unstructured":"Segura, A. M., Frazier, O. H. & Buja, L. M. Fibrosis and heart failure. Heart Fail. Rev. 19, 173\u2013185 (2014).","journal-title":"Heart Fail. Rev."},{"key":"11551_CR74","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1111\/j.1755-5922.2010.00228.x","volume":"30","author":"AJ Edgley","year":"2012","unstructured":"Edgley, A. J., Krum, H. & Kelly, D. J. Targeting fibrosis for the treatment of heart failure: a role for transforming growth factor-beta. Cardiovasc. Ther. 30, e30\u2013e40 (2012).","journal-title":"Cardiovasc. Ther."},{"key":"11551_CR75","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1101\/gr.169029.113","volume":"24","author":"C Rintisch","year":"2014","unstructured":"Rintisch, C. et al. Natural variation of histone modification and its impact on gene expression in the rat genome. Genome Res. 24, 942\u2013953 (2014).","journal-title":"Genome Res."},{"key":"11551_CR76","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrg3068","volume":"12","author":"JA Martin","year":"2011","unstructured":"Martin, J. A. & Wang, Z. Next-generation transcriptome assembly. Nat. Rev. Genet. 12, 671\u2013682 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"11551_CR77","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1371\/journal.pgen.0030161","volume":"3","author":"JT Leek","year":"2007","unstructured":"Leek, J. T. & Storey, J. D. Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet. 3, 1724\u20131735 (2007).","journal-title":"PLoS Genet"},{"key":"11551_CR78","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/eurheartj\/ehp549","volume":"31","author":"B Heidecker","year":"2010","unstructured":"Heidecker, B. et al. The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences. Eur. Heart J. 31, 1188\u20131196 (2010).","journal-title":"Eur. Heart J."},{"key":"11551_CR79","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-220","volume":"8","author":"J Hardin","year":"2007","unstructured":"Hardin, J., Mitani, A., Hicks, L. & VanKoten, B. A robust measure of correlation between two genes on a microarray. BMC Bioinformatics 8, 220 (2007).","journal-title":"BMC Bioinformatics"},{"key":"11551_CR80","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1093\/bioinformatics\/btp502","volume":"25","author":"Y Choi","year":"2009","unstructured":"Choi, Y. & Kendziorski, C. Statistical methods for gene set co-expression analysis. Bioinformatics 25, 2780\u20132786 (2009).","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s41467-019-12060-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11551-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11551-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11551-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T19:41:59Z","timestamp":1671219719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11551-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["11551"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-11551-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"10 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An amendment to this paper has been published and can be accessed via a link at the top of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.P. and A.M.-M. have filed a patent (application number 1908544.8; status: \u201cprovisional application\u201d; date 14 June 2019) concerning the treatment and\/or prevention of disease through inhibition of the pro-fibrotic functions of WWP2. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3616"}}